An oncology-focused company with advanced-stage diagnostic tech and a promising antibody-based cancer treatment pipeline. Ticker symbol: BUX.c

ID: 2648769758

linkhttp://www.biomarkdiagnostics.com calendar_today15-07-2014 17:19:41